Entry Point Capital, LLC Cerus Corp Transaction History
Entry Point Capital, LLC
- $246 Million
- Q3 2025
A detailed history of Entry Point Capital, LLC transactions in Cerus Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 163,833 shares of CERS stock, worth $265,409. This represents 0.11% of its overall portfolio holdings.
Number of Shares
163,833
Previous 134,312
21.98%
Holding current value
$265,409
Previous $189,000
37.57%
% of portfolio
0.11%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding CERS
# of Institutions
166Shares Held
135MCall Options Held
126KPut Options Held
30.1K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl18.9MShares$30.5 Million0.21% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$22.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$17.5 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY10MShares$16.2 Million0.13% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.69MShares$9.21 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $287M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...